Tuesday, November 24, 2020
Home Life Style Health & Fitness This Cancer Drug Improves Hospital Survival in Critically ill Covid-19 Patients

This Cancer Drug Improves Hospital Survival in Critically ill Covid-19 Patients

Tocilizumab improves survival in sickest Covid-19 patients

A drug normally used in rheumatoid arthritis and cancer treatments — tocilizumab — improves hospital survival in critically ill Covid-19 patients admitted to the intensive care unit (ICU), say researchers.

The study, published in the journal The Lancet Rheumatology, included 630 patients who were admitted to the ICUs of 13 Hackensack Meridian Health hospitals in New Jersey.

Among other treatments, tocilizumab was considered for off-label usage for the patients whose respiratory symptoms were declining; many of whom were requiring mechanical ventilator support.

Follow NewsGram on LinkedIn to know what’s happening around the world.

In the observational study, 210 patients received tocilizumab, and the other 420 did not.

“Our work in treating this terrible virus, and learning more about it each day, continues to benefit thousands of patients as the pandemic continues,” said Robert C Garrett, CEO from the Hackensack Meridian Health in the US.

This drug improves survival in sickest Covid-19 patients: Study
Tocilizumab is a monoclonal antibody, which binds and blocks the interleukin (IL)-6 receptor and helps damper the inflammatory response. Pinterest

Covid-19 has three phases: the early or viral phase (with fast viral replication), the pulmonary phase (marked by inflammation and pneumonia as the body tries to fight the virus in the lungs) and the inflammatory phase (in which excessive inflammation reaches and affects many organs and patients are often in the ICU).

As part of both the pulmonary and inflammatory phases, the immune system is “supercharged” and secretes in the blood numerous cytokines, particularly interleukin (IL)-6, which induces further inflammation.

Tocilizumab is a monoclonal antibody, which binds and blocks the interleukin (IL)-6 receptor and helps damper the inflammatory response.

Want to read more in Hindi? Checkout: कोरोना के दौर में ‘वर्क फ्रॉम होम’ वालों की भी कहानी सुनने लायक 

The activity of tocilizumab was first shown in chimeric antigen receptor (CAR) T-cell therapy, where a similar phenomenon of overactive and growing T cells induce a “cytokine storm.”

This provided a rationale to try tocilizumab in Covid-19 patients.

The findings showed a statistically significant decrease in hospital-related deaths among the patients who received the tocilizumab.

This drug improves survival in sickest Covid-19 patients: Study
There was roughly 36% decrease in hospital-related mortality among the ICU patients who received the drug, as compared with patients in the ICU who didn’t receive it. Pinterest

A roughly 36 per cent decrease in hospital-related mortality among the ICU patients who received the drug, as compared with patients in the ICU who didn’t receive it.

Also Read: I Feel Comedy can be Utilised for Positive Changes: Vir Das

Importantly, it appeared that higher levels of a blood test marker of inflammation, C-reactive protein, could predict which ICU patients might benefit most from the tocilizumab therapy, potentially allowing doctors to tailor therapy to those most in need.

“These real-time findings have helped to point us the way forward,” the study authors wrote.

Earlier this month, another study published in the International Journal of Infectious Diseases, found that patients experiencing severe Covid-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,783FollowersFollow

Most Popular

Snapchat Releases Spotlight, To Pay Top Creators

Taking on TikTok, Popular photo-messaging platform Snapchat on Monday officially released Spotlight where Snapchatters will also have the opportunity to earn as they do...

Care For COVID+ Mothers and Newborn Babies

Many COVID-19 positive pregnant women experience mild symptoms of cold or flu. However, pregnant women who are older, overweight, or have pre-existing medical conditions...

MP Govt To Produce Clean Fuel From Stubble Burnt

The Madhya Pradesh government has proposed a plan to set up an industrial unit producing fuel from stubble burnt by the farmers in the...

Felling of 315 Trees When Air Quality is Worse in Delhi

The Delhi High Court on Monday sought a response from the AAP government and others over a petition against an order for felling of...

Cyber Frauds May Increase in India in 2021: Kaspersky

With more users getting connected to the Internet and entering the digital payments ecosystem, cyber fraud incidents may go up in 2021, a researcher...

UP Marks Record in Production And Sales of Sanitizers

The Yogi Adityanath government in Uttar Pradesh has used the 'opportunity in adversity' concept to create a record of sorts in the production and...

Greater Risks of STI in People Above 45

Researchers have found that people above 45s are at a higher risk of contracting sexually transmitted infections (STIs) than ever before because of society's...

SC Happy About Permanent Commission of Women Army Officers

The Supreme Court on Monday expressed happiness after learning that the Centre has implemented its verdict to grant permanent commission to women officers in...

Recent Comments